Copy For Citation
ARAZ-ERSAN B., Kir N., Tuncer S., Aydinoglu-Candan O., Yildiz-Inec D., Akdogan B., ...More
CURRENT EYE RESEARCH, vol.40, no.6, pp.585-591, 2015 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
40
Issue:
6
-
Publication Date:
2015
-
Doi Number:
10.3109/02713683.2014.941070
-
Journal Name:
CURRENT EYE RESEARCH
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.585-591
-
Keywords:
Antivascular endothelial growth factor, bevacizumab, retinopathy of prematurity, ENDOTHELIAL GROWTH-FACTOR, INJECTION, SAFETY, AVASTIN, BAYLEY, CHILD, ROP
-
Istanbul University Affiliated:
Yes
Abstract
Purpose: To evaluate the two-year follow-up of patients with type 1 retinopathy of prematurity (ROP) who received intravitreal bevacizumab (IVB) as adjunctive treatment.